(Updated - July 18, 2024 6:17 AM EDT)

BofA Securities analyst Kevin Fischbeck downgraded Elevance (NYSE: ELV) from Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Downgrades

Elevance (ELV) PT Raised to $585 at RBC CapitalJuly 18, 2024 6:13 AM Elevance (ELV) PT Lowered to $600 at JefferiesJuly 18, 2024 5:59 AM Elevance (ELV) PT Lowered to $611 at BarclaysJuly 18, 2024 5:54 AM Form 10-Q Elevance Health, Inc. For: Jun 30July 17, 2024 3:02 PM Morgan Stanley Reiterates Overweight Rating on Elevance (ELV)July 17, 2024 8:28 AM Truist Securities Reiterates Buy Rating on Elevance (ELV)July 17, 2024 8:28 AM Form 8-K Elevance Health, Inc. For: Jul 17July 17, 2024 6:10 AM Elevance Health Inc. (ELV) Tops Q2 EPS by 11cJuly 17, 2024 6:03 AM Elevance Health Reports Second Quarter 2024 ResultsJuly 17, 2024 6:00 AM TD Cowen Reiterates Buy Rating on Elevance (ELV)July 16, 2024 7:19 AM